Mesenchymal Stem Cell-Based Immunomodulation: Properties and Clinical Application

Figure 1

The clinical trial distribution of MSC-based immunomodulation in the world. Up to now, most of the clinical trials using MSCs for treating inflammatory or autoimmune diseases have been conducted in the China, US, and Europe. All values have been extracted from https://clinicaltrials.gov/.